/PRNewswire/ Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation.
Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Thousands of central Ohioans diagnosed with sleep apnea potentially impacted by Philips Respironics recall
It was discovered that toxins were leaking from a foam material that keeps the machines running smoothly and quietly. Author: Lindsey Mills Updated: 7:19 PM EDT July 16, 2021
COLUMBUS, Ohio “It is an inconvenience,” said Mark Fisher, who depends on two Philips Respironics devices, both affected by an FDA recall issued June 30.
“I have used a filter as recommended over the output port so I can still use my device until it can be repaired or replaced,” he explained.
Earlier last month, Philips Respironics advised patients using BiLevel PAP and CPAP devices to stop using them.